Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |